AMBISOME Side Effects

7025109-8 | Back Pain, Blood Lactate Dehydrogenase Increased, Choluria, Haemolytic Anaemia
on Sep 20, 2010 Male patient from SPAIN , 72 years of age, was diagnosed with febrile neutropenia and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), blood lactate dehydrogenase increased, choluria, haemolytic anaemia. Ambisome dosage: Iv Nos. During the same period patient was treated with CEFEPIME (View Cefepime Review and Cefepime Label ), AMIKACINA (AMIKACIN SULFATE) (View Amikacina (amikacin Sulfate) Review and Amikacina (amikacin Sulfate) Label ), VANCOMICINA (VANCOMYCIN) (View Vancomicina (vancomycin) Review and Vancomicina (vancomycin) Label ). Patient was hospitalized.

7021884-7 | Hyperkalaemia, Hypoglycaemia
Patient was taking Ambisome (View Usage). Patient had the following side effects: hyperkalaemia, hypoglycaemia on Sep 21, 2010 from JAPAN Additional patient health information: Female patient , 86 years of age, was diagnosed with pneumonia cryptococcal and. Ambisome dosage: 32 Mg, Uid/qd, Iv Nos.

7021883-5 | Candida Test Positive, Dyspnoea, Haemodialysis-induced Symptom, Laboratory Test Abnormal, Nephrogenic Anaemia, Pancytopenia, Pyrexia
Adverse event was reported on Sep 16, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: See Image) was diagnosed with systemic mycosis, upper gastrointestinal haemorrhage and. Location: JAPAN , 50 years of age, After Ambisome was administered, patient had the following side effects: candida test positive, dyspnoea, haemodialysis-induced symptom, laboratory test abnormal, nephrogenic anaemia, pancytopenia, pyrexia. During the same period patient was treated with ZANTAC (50 Mg, Uid/qd) (View Zantac Review and Zantac Label ), OMEPRAZOLE (20 Mg, Uid/qd) (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

7020842-6 | Cholestasis, Disease Progression, Leukopenia, Lung Infiltration, Pyrexia, Somnolence, Waldenstrom's Macroglobulinaemia
on Sep 17, 2010 Male patient from FRANCE , 71 years of age, weighting 149.9 lb, was diagnosed with antifungal treatment and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, disease progression, leukopenia, lung infiltration, pyrexia, somnolence, waldenstrom's macroglobulinaemia. Ambisome dosage: 680 G, Uid/qd, Iv Nos; 3 Mg/kg, Uid/qd, Iv Nos. Patient was hospitalized.


7017981-2 | Ventricular Tachycardia
on Sep 14, 2010 Female patient from BRAZIL , weighting 6.61 lb, was diagnosed with antifungal treatment and was treated with Ambisome (View Usage). Patient had the following side effects: ventricular tachycardia. Ambisome dosage: 5 Mg/kg, Iv Nos. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

7015562-8 | Acute Myeloid Leukaemia, Condition Aggravated
Patient was taking Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: acute myeloid leukaemia, condition aggravated on Sep 17, 2010 from JAPAN Additional patient health information: Male patient , 38 years of age, was diagnosed with acute myeloid leukaemia and. Ambisome dosage: 150 Mg, Uid/qd, Iv Nos.

7005520-1 | Acute Coronary Syndrome, Electrocardiogram Qt Prolonged, Electrolyte Imbalance, Loss Of Consciousness, Ventricular Fibrillation
Adverse event was reported on Sep 10, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 100 Mg, Uid/qd, Iv Nos; 200 Mg, Uid/qd, Iv Nos) was diagnosed with bronchopulmonary aspergillosis and. Location: JAPAN , 71 years of age, Patient experienced the following unwanted or unexpected effects: acute coronary syndrome, electrocardiogram qt prolonged, electrolyte imbalance, loss of consciousness, ventricular fibrillation. During the same period patient was treated with VFEND (View Vfend Review and Vfend Label ), COLDRIN (CLOFEDANOL HYDROCHLORIDE) (View Coldrin (clofedanol Hydrochloride) Review and Coldrin (clofedanol Hydrochloride) Label ), AGENTS FOR PEPTIC ULCER (View Agents For Peptic Ulcer Review and Agents For Peptic Ulcer Label ).

6992603-5 | Cholestasis, Leukopenia, Lung Infiltration, Pyrexia
on Sep 09, 2010 Male patient from FRANCE , 71 years of age, weighting 149.9 lb, was diagnosed with antifungal treatment and was treated with Ambisome (View Usage). Patient had the following side effects: cholestasis, leukopenia, lung infiltration, pyrexia. Ambisome dosage: 680 G, Uid/qd, Iv Nos; 3 Mg/kg, Uid/qd, Iv Nos. Patient was hospitalized.

6987603-5 | Neutropenia
on Sep 07, 2010 Male patient from FRANCE , 21 years of age, weighting 132.3 lb, was diagnosed with fungal infection (What is fungal infection?), osteitis and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: neutropenia. Ambisome dosage: 600 Mg, Uid/qd, Iv Nos. During the same period patient was treated with AMOXICILLINE (AMOXICILLIN SODIUM) (12 G Uid/qd, Iv Nos) (View Amoxicilline (amoxicillin Sodium) Review and Amoxicilline (amoxicillin Sodium) Label ), VANCOMYCIN (2 G, Uid/qd, Iv Nos) (View Vancomycin Review and Vancomycin Label ), RIFAMPICIN (1200 Mg, Uid/qd, Oral) (View Rifampicin Review and Rifampicin Label ). Patient was hospitalized.

6980438-9 | Cholestasis
Patient was taking Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis on Aug 30, 2010 from FRANCE Additional patient health information: Male patient , 71 years of age, weighting 149.9 lb, . Ambisome dosage: 680 G, Uid/qd. Iv Nos, 3 Mg/kg, Uid/qd, Iv Nos.

6967393-2 | Deafness
Adverse event was reported on Aug 23, 2010 by a Female patient taking Ambisome (View Usage) (Dosage: 200 Mg, Uid/qd, Iv Nos) was diagnosed with candidiasis and. Location: UNITED KINGDOM , 64 years of age, weighting 121.3 lb, Patient had the following side effects: deafness. During the same period patient was treated with SOLUTIONS FOR PARENTERAL NUTRITION (View Solutions For Parenteral Nutrition Review and Solutions For Parenteral Nutrition Label ), ELECTROLYTE SOLUTIONS (View Electrolyte Solutions Review and Electrolyte Solutions Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CO AMOXICILLIN (AMOXICILLIN SODIUM, CLAVULANATE, POTASSIUM) (View Co-amoxicillin (amoxicillin Sodium, Clavulanate, Potassium) Review and Co-amoxicillin (amoxicillin Sodium, Clavulanate, Potassium) Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ).

6964071-0 | Obliterative Bronchiolitis, Renal Failure, Respiratory Failure, Tracheomalacia
on Aug 25, 2010 Female patient from GERMANY , 49 years of age, was diagnosed with cerebral aspergillosis and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: obliterative bronchiolitis, renal failure, respiratory failure, tracheomalacia. Ambisome dosage: 75 Mg, Iv Nos. During the same period patient was treated with EXJADE (1500 Mg, Oral) (View Exjade Review and Exjade Label ).

6963929-6 | Hypokalaemia, Pneumonitis
on Aug 24, 2010 Female patient from JAPAN , 54 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia, pneumonitis. Ambisome dosage: 75 Mg, Uid/qd, Iv Nos.

6946248-3 | Respiratory Disorder, Stevens-johnson Syndrome
Patient was taking Ambisome (View Usage). Patient had the following side effects: respiratory disorder, stevens-johnson syndrome on Aug 17, 2010 from BRAZIL Additional patient health information: Female patient , 35 years of age, weighting 154.3 lb, was diagnosed with infection (What is infection?) and. Ambisome dosage: 240 Mg, D. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), TARGOCID (View Targocid Review and Targocid Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), PHENYTOIN (View Phenytoin Review and Phenytoin Label ), CEFEPIME (View Cefepime Review and Cefepime Label ), RITUXIMAB (RITUXIMAB) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), NOREPINEPHRINE BITARTRATE (View Norepinephrine Bitartrate Review and Norepinephrine Bitartrate Label ).

6936853-2 | Bone Erosion, Ischaemic Cerebral Infarction, Sinus Disorder
Adverse event was reported on Aug 11, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: ) was diagnosed with mucormycosis and. Location: PORTUGAL , 78 years of age, After Ambisome was administered, patient had the following side effects: bone erosion, ischaemic cerebral infarction, sinus disorder. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CANDESARTAN W/HYDROCHLOROTHIAZIDE (CANDESARTAN, HYDROCHLOROTHIAZIDE) (View Candesartan W/hydrochlorothiazide (candesartan, Hydrochlorothiazide) Review and Candesartan W/hydrochlorothiazide (candesartan, Hydrochlorothiazide) Label ).

6936851-9 | Ventricular Tachycardia
on Aug 09, 2010 Female patient from BRAZIL , weighting 6.61 lb, was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: ventricular tachycardia. Ambisome dosage: 5 Mg/kg, Iv Nos. During the same period patient was treated with MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), KETAMINE HCL (View Ketamine Hcl Review and Ketamine Hcl Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), LASIX (View Lasix Review and Lasix Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), DIGOXIN (View Digoxin Review and Digoxin Label ).

6935863-9 | Cardiac Arrest, Ventricular Tachycardia
on Aug 09, 2010 Male patient from BRAZIL , child 8 years of age, weighting 44.09 lb, was treated with Ambisome (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), ventricular tachycardia. Ambisome dosage: 5 Mg/kg, /d, Iv Nos. During the same period patient was treated with DORMONID (MIDAZOLAM) (View Dormonid (midazolam) Review and Dormonid (midazolam) Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), TRANSAMIN (TRANEXAMIC ACID) (View Transamin (tranexamic Acid) Review and Transamin (tranexamic Acid) Label ), VITAMIN K (VITAMIN K NOS) (View Vitamin K (vitamin K Nos) Review and Vitamin K (vitamin K Nos) Label ), HYDRALAZINE (View Hydralazine Review and Hydralazine Label ).

6929970-4 | Toxic Skin Eruption
Patient was taking Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: toxic skin eruption on Aug 04, 2010 from SPAIN Additional patient health information: Male patient , 72 years of age, was diagnosed with candidiasis and. Ambisome dosage: 75 Mg, Uid/qd, Iv Nos. During the same period patient was treated with PIPERACILLIN W/TAZOBACTAM (PIPERACILLIN, TAZOBACTAM) (View Piperacillin W/tazobactam (piperacillin, Tazobactam) Review and Piperacillin W/tazobactam (piperacillin, Tazobactam) Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TIGECYCLINE (View Tigecycline Review and Tigecycline Label ), DROTRECOGIN ALFA (View Drotrecogin Alfa Review and Drotrecogin Alfa Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6925467-6 | Blood Creatinine Increased
Adverse event was reported on Aug 13, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 350mg Daily Iv) . Location: UNITED STATES , weighting 238.0 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased.

6925324-5 | Pneumonitis
on Aug 05, 2010 Female patient from JAPAN , 58 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Ambisome (View Usage). Patient had the following side effects: pneumonitis. Ambisome dosage: .

6916508-0 | Sepsis
on Jul 30, 2010 Female patient from PORTUGAL , 62 years of age, weighting 264.6 lb, was diagnosed with candidiasis, condition aggravated and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: sepsis (What is sepsis?). Ambisome dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6902532-0 | Pancreatitis Acute
Patient was taking Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: pancreatitis acute on Jul 21, 2010 from JAPAN Additional patient health information: Female patient , 51 years of age, was diagnosed with bronchopulmonary aspergillosis and. Ambisome dosage: 150 Mg, 100mg Uid/qd, Iv Nos. During the same period patient was treated with MYCAMINE (View Mycamine Review and Mycamine Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), HUMAN SERUM ALBUMIN (ALBUMIN) (View Human Serum Albumin (albumin) Review and Human Serum Albumin (albumin) Label ).

6896579-0 | Blood Cholesterol Increased, Dyslipidaemia, Hypokalaemia, Renal Disorder
Adverse event was reported on Jul 20, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 400 Mg, Uid/qd, Iv Drip) was diagnosed with meningitis cryptococcal and. Location: JAPAN , 30 years of age, Patient had the following side effects: blood cholesterol increased, dyslipidaemia, hypokalaemia, renal disorder. Patient was hospitalized.

6870638-0 | Sepsis
on Jul 14, 2010 Female patient from PORTUGAL , 62 years of age, weighting 264.6 lb, was diagnosed with candidiasis and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: sepsis (What is sepsis?). Ambisome dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6865827-5 | Cardiac Arrest, Ileus Paralytic, Pancreatitis Acute
on Jul 13, 2010 Female patient from JAPAN , child 6 years of age, was diagnosed with pneumonia (What is pneumonia?), pneumonia staphylococcal, hypokalaemia, liver disorder, convulsion and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), ileus paralytic, pancreatitis acute. Ambisome dosage: 75 Mg, Uid/qd, Iv Drip, 100 Mg, Uid/qd, Iv Drip. During the same period patient was treated with ZOSYN (9 G, Uid/qd, Iv Drip) (View Zosyn Review and Zosyn Label ), HEPARIN SODIUM (10 Iu, Uid/qd, Iv Nos) (View Heparin Sodium Review and Heparin Sodium Label ), TARGOID (TEICOPLANIN) (150 Mg, Uid/qd, Iv Drip) (View Targoid (teicoplanin) Review and Targoid (teicoplanin) Label ), ASPARA K (ASPARTATE POTASSIUM) (30 Meq, Uid/qd, Iv Nos) (View Aspara K (aspartate Potassium) Review and Aspara K (aspartate Potassium) Label ), NEO MINOPHAGEN C (GLYCYRRHIZIC ACID, AMMONIUM SALT) (40 Ml, Uid/qd, Iv Drip) (View Neo-minophagen C (glycyrrhizic Acid, Ammonium Salt) Review and Neo-minophagen C (glycyrrhizic Acid, Ammonium Salt) Label ), DORIBAX (0.5 G, Uid/qd, Iv Drip) (View Doribax Review and Doribax Label ), MIDAZOLAM HCL (80 Mg, Uid/qd, Iv Drip) (View Midazolam Hcl Review and Midazolam Hcl Label ).

6857970-1 | Hypokalaemia, Lipids Abnormal
Patient was taking Ambisome (View Usage). Patient had the following side effects: hypokalaemia, lipids abnormal on Jul 05, 2010 from JAPAN Additional patient health information: Male patient , 30 years of age, was diagnosed with meningitis cryptococcal and. Ambisome dosage: 400 Mg, Uid/qd, Iv Drip. Patient was hospitalized.

6846760-1 | Blood Pressure Systolic Increased, Cardio-respiratory Arrest, Hypokalaemia, Loss Of Consciousness, Tooth Extraction, Ventricular Fibrillation
Adverse event was reported on Jul 07, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 200 Mg, Uid/qd, Iv Nos) was diagnosed with sinusitis (What is sinusitis?) and. Location: JAPAN , 70 years of age, After Ambisome was administered, patient had the following side effects: blood pressure systolic increased, cardio-respiratory arrest, hypokalaemia, loss of consciousness, tooth extraction, ventricular fibrillation. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ACLARUBICIN HYDROCHLORIDE (ACLARUBICIN HYDROCHLORIDE) (View Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Review and Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Label ), GRANULOCYTE COLONY STIMULATING FACTOR (GRANULOCYTE COLONY STIMULATING (View Granulocyte Colony Stimulating Factor (granulocyte Colony Stimulating Review and Granulocyte Colony Stimulating Factor (granulocyte Colony Stimulating Label ), PLATELETS (View Platelets Review and Platelets Label ).

6846701-7 | Blood Creatinine Increased, Pyrexia
on Jun 29, 2010 Male patient from JAPAN , 58 years of age, was diagnosed with meningitis cryptococcal and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, pyrexia. Ambisome dosage: 4 Mg/kg, Uid/qd, Iv Nos. During the same period patient was treated with ANCOTIL (FLUCYTOSINE) (View Ancotil (flucytosine) Review and Ancotil (flucytosine) Label ), VFEND (View Vfend Review and Vfend Label ). Patient was hospitalized.

6832257-1 | Bone Erosion, Ischaemic Cerebral Infarction, Sinus Disorder
on Jun 30, 2010 Male patient from PORTUGAL , 78 years of age, was diagnosed with mucormycosis and was treated with Ambisome (View Usage). Patient had the following side effects: bone erosion, ischaemic cerebral infarction, sinus disorder. Ambisome dosage: .

6816607-8 | Back Pain, Infusion Related Reaction
Patient was taking Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: back pain (What is back pain?), infusion related reaction on Jun 22, 2010 from GREECE Additional patient health information: Female patient , 27 years of age, weighting 132.3 lb, was diagnosed with febrile neutropenia and. Ambisome dosage: 300 Df, Uid/qd; Iv Nos. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GRANOCYTE (LENOGRASTIM) (View Granocyte (lenograstim) Review and Granocyte (lenograstim) Label ).

6816604-2 | Back Pain, Disease Complication, Non-hodgkin's Lymphoma
Adverse event was reported on Jun 22, 2010 by a Female patient taking Ambisome (View Usage) (Dosage: 300 Df, Uid/qd, Iv Nos) was diagnosed with febrile neutropenia and. Location: GREECE , 27 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), disease complication, non-hodgkin's lymphoma. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MORPHINE (View Morphine Review and Morphine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), GRANOCYTE (LENOGRASTIM) (View Granocyte (lenograstim) Review and Granocyte (lenograstim) Label ).

6816588-7 | Muscle Disorder
on Jun 21, 2010 Male patient from SPAIN , 17 years of age, was diagnosed with candidiasis, evidence based treatment and was treated with Ambisome (View Usage). Patient had the following side effects: muscle disorder (What is muscle disorder?). Ambisome dosage: 2 To 3 Mg/kg, Iv Nos.

6816587-5 | Apparent Life Threatening Event, Cardio-respiratory Arrest, Heart Rate Increased, Hypokalaemia, Loss Of Consciousness, Pancytopenia, Ventricular Fibrillation
on Jun 21, 2010 Male patient from JAPAN , 70 years of age, was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: apparent life threatening event, cardio-respiratory arrest, heart rate increased, hypokalaemia, loss of consciousness, pancytopenia, ventricular fibrillation. Ambisome dosage: 200 Mg, Uid/qd, Iv Nos. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ACLARUBICIN HYDROCHLORIDE (ACLARUBICIN HYDROCHLORIDE) (View Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Review and Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Label ), GRANULOCYTE COLONG STIMULATING FACTOR (GRANULOCYTE COLONY STIMULATING (View Granulocyte Colong Stimulating Factor (granulocyte Colony Stimulating Review and Granulocyte Colong Stimulating Factor (granulocyte Colony Stimulating Label ).

6816584-X | Blood Potassium Decreased, Clonic Convulsion, Respiratory Distress, Rhabdomyolysis, Tachypnoea
Patient was taking Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium decreased, clonic convulsion, respiratory distress, rhabdomyolysis, tachypnoea on Jun 21, 2010 from JAPAN Additional patient health information: Female patient , 25 years of age, was diagnosed with sepsis (What is sepsis?), endotracheal intubation, sedation and. Ambisome dosage: 200 Mg, Uid/qd, Iv Drip. During the same period patient was treated with VECURONIUM BROMIDE (8 Mg, Total Dose) (View Vecuronium Bromide Review and Vecuronium Bromide Label ), PROPOFOL (Iv Nos) (View Propofol Review and Propofol Label ), PENTAZOCINE LACTATE (Iv Nos) (View Pentazocine Lactate Review and Pentazocine Lactate Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), MAXIPIME (View Maxipime Review and Maxipime Label ), PENICILLIN G POTASSIUM (View Penicillin G Potassium Review and Penicillin G Potassium Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

6797409-8 | Cardio-respiratory Arrest, Hypokalaemia, Ventricular Fibrillation
Adverse event was reported on Jun 17, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 200 Mg, Uid/qd, Iv Nos) . Location: JAPAN , 70 years of age, Patient had the following side effects: cardio-respiratory arrest, hypokalaemia, ventricular fibrillation. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ACLARUBICIN HYDROCHLORIDE (ACLARUBICIN HYDROCHLORIDE) (View Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Review and Aclarubicin Hydrochloride (aclarubicin Hydrochloride) Label ), GRANULOCYTE COLONY STIMULATING FACTOR (GRANULOCYTE COLONY STIMULATING (View Granulocyte Colony Stimulating Factor (granulocyte Colony Stimulating Review and Granulocyte Colony Stimulating Factor (granulocyte Colony Stimulating Label ).

6796329-2 | Toxic Skin Eruption
on May 25, 2010 Male patient from SPAIN , 45 years of age, weighting 198.4 lb, was diagnosed with candidiasis and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: toxic skin eruption. Ambisome dosage: 300 Mg, Uid/qd, Iv Nos. During the same period patient was treated with PANTOPRAZOL (PANTOPRAZOLE SODIUM) (View Pantoprazol (pantoprazole Sodium) Review and Pantoprazol (pantoprazole Sodium) Label ), TAZOCEL (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM) (View Tazocel (piperacillin Sodium, Tazobactam Sodium) Review and Tazocel (piperacillin Sodium, Tazobactam Sodium) Label ), NORADRENALINA (NOREPINEPHRINE) (View Noradrenalina (norepinephrine) Review and Noradrenalina (norepinephrine) Label ), OPIOIDS (View Opioids Review and Opioids Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), TIGLECINE (TIGLECINE) (View Tiglecine (tiglecine) Review and Tiglecine (tiglecine) Label ).

6796328-0 | Cardiac Arrest, Ileus Paralytic, Oxygen Saturation Decreased, Pancreatitis Acute, Shock
on Jun 15, 2010 Female patient from JAPAN , child 6 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), ileus paralytic, oxygen saturation decreased, pancreatitis acute, shock. Ambisome dosage: 75 Mg, Uid/qd, Iv Drip; 100 Mg, Uid/qd, Iv Drip. During the same period patient was treated with ZOSYN (9 Mg, Uid/qd, Iv Drip) (View Zosyn Review and Zosyn Label ), DORIBAX (0.5 Mg, Uid/qd, Iv Drip) (View Doribax Review and Doribax Label ), TARGOCID (150 Mg, Uid/qd, Iv Drip) (View Targocid Review and Targocid Label ), ASPARTATE POTASSIUM (ASPARTATE POTASSIUM) (View Aspartate Potassium (aspartate Potassium) Review and Aspartate Potassium (aspartate Potassium) Label ), NEO MINOPHAGEN C (GLYCYRRHIZIC ACID, AMMONIUM SALT) (View Neo-minophagen C (glycyrrhizic Acid, Ammonium Salt) Review and Neo-minophagen C (glycyrrhizic Acid, Ammonium Salt) Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ).

6796213-4 | Flushing, Infusion Related Reaction, Muscle Spasms
Patient was taking Ambisome (View Usage). Patient had the following side effects: flushing, infusion related reaction, muscle spasms on Jun 24, 2010 from UNITED STATES Additional patient health information: Male patient , 34 years of age, weighting 209.4 lb, was diagnosed with leishmaniasis (What is leishmaniasis?) and. Ambisome dosage: 269 Mg Iv Once Dialy. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DIPHENHYDROMINE (View Diphenhydromine Review and Diphenhydromine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ).

6785104-0 | Chest Pain, Respiratory Distress
Adverse event was reported on Jun 09, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: ) was diagnosed with opportunistic infection and. Location: ARGENTINA , 24 years of age, After Ambisome was administered, patient had the following side effects: chest pain (What is chest pain?), respiratory distress.

6764119-2 | Cardiac Arrest, Septic Shock, Urinary Tract Infection
on May 28, 2010 Male patient from JAPAN , 76 years of age, was diagnosed with meningitis cryptococcal and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), septic shock, urinary tract infection (What is urinary tract infection?). Ambisome dosage: Unk, Iv Drip. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), FLUCYTOSINE (FLUCYTOSINE) (View Flucytosine (flucytosine) Review and Flucytosine (flucytosine) Label ).

6764118-0 | Back Pain, Non-hodgkin's Lymphoma
on Jun 01, 2010 Female patient from GREECE , 27 years of age, weighting 132.3 lb, was diagnosed with febrile neutropenia and was treated with Ambisome (View Usage). Patient had the following side effects: back pain (What is back pain?), non-hodgkin's lymphoma. Ambisome dosage: 300 Df, Uid/qd, Iv Nos. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MORPHINE (View Morphine Review and Morphine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), GRANOCYTE (LENOGRASTIM) (View Granocyte (lenograstim) Review and Granocyte (lenograstim) Label ).

6761471-9 | Rash Erythematous, Toxic Skin Eruption
Patient was taking Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: rash erythematous, toxic skin eruption on May 25, 2010 from SPAIN Additional patient health information: Male patient , 45 years of age, weighting 198.4 lb, was diagnosed with candidiasis and. Ambisome dosage: 300 Mguid/qd; Iv Nos. During the same period patient was treated with PANTOPRAZOL (PANTOPRAZOLE SODIUM) (View Pantoprazol (pantoprazole Sodium) Review and Pantoprazol (pantoprazole Sodium) Label ), TAZOCEL (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM) (View Tazocel (piperacillin Sodium, Tazobactam Sodium) Review and Tazocel (piperacillin Sodium, Tazobactam Sodium) Label ), NORADRENALINA (NOREPINEPHRINE) (View Noradrenalina (norepinephrine) Review and Noradrenalina (norepinephrine) Label ), OPIOIDS (View Opioids Review and Opioids Label ), BENZODIAZEPINE DERIVATIVES (View Benzodiazepine Derivatives Review and Benzodiazepine Derivatives Label ), TIGLECINE (TIGLECINE) (View Tiglecine (tiglecine) Review and Tiglecine (tiglecine) Label ).

6758987-8 | Candida Test Positive, Pancytopenia, Pyrexia
Adverse event was reported on May 25, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: See Image) was diagnosed with systemic mycosis and. Location: JAPAN , 50 years of age, Patient experienced the following unwanted or unexpected effects: candida test positive, pancytopenia, pyrexia. During the same period patient was treated with ZANTAC 150 (View Zantac 150 Review and Zantac 150 Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ). Patient was hospitalized.

6758812-5 | Acute Lymphocytic Leukaemia, Disseminated Intravascular Coagulation, Malignant Neoplasm Progression, Renal Impairment, Respiratory Failure, Sepsis, Torsade De Pointes, Ventricular Extrasystoles, Ventricular Tachycardia
on May 27, 2010 Male patient from JAPAN , 14 years of age, weighting 167.6 lb, was diagnosed with bronchopulmonary aspergillosis, fungal infection (What is fungal infection?), sepsis (What is sepsis?), white blood cell count decreased and was treated with Ambisome (View Usage). Patient had the following side effects: acute lymphocytic leukaemia, disseminated intravascular coagulation, malignant neoplasm progression, renal impairment, respiratory failure, sepsis (What is sepsis?), torsade de pointes, ventricular extrasystoles, ventricular tachycardia. Ambisome dosage: 350 Mg, Uid/qd, Iv Nos. During the same period patient was treated with FUNGUARD (MICAFUNGIN) INJECTION (150 Mg, Uid/qd, Iv Nos) (View Funguard (micafungin) Injection Review and Funguard (micafungin) Injection Label ), VFEND (400 Mg, Uid/qd, Iv Nos; 200 Mg, Bid, Iv Nos) (View Vfend Review and Vfend Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), AMIKACIN SULFATE (400 Mg, Uid/qd, Iv Nos; 200 Mg, Uid/qd, Iv Nos) (View Amikacin Sulfate Review and Amikacin Sulfate Label ), NEUTROGIN (LENOGRASTIM) (250 Ug, Uid/qd, Iv Nos; 450 Ug, Uid/qd, Iv Nos) (View Neutrogin (lenograstim) Review and Neutrogin (lenograstim) Label ).

6751385-2 | Anaphylactic Shock, Loss Of Consciousness, Organising Pneumonia
on May 19, 2010 Male patient from JAPAN , 65 years of age, was diagnosed with pneumonia fungal and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: anaphylactic shock, loss of consciousness, organising pneumonia. Ambisome dosage: 125 Mg, Total Dose, Iv Nos. During the same period patient was treated with FIRSTCIN (CEFOZOPRAN HYDROCHLORIDE) (View Firstcin (cefozopran Hydrochloride) Review and Firstcin (cefozopran Hydrochloride) Label ), UNASYN (View Unasyn Review and Unasyn Label ), DALACIN ST (CLINDAMYCIN PHOSPHATE) (View Dalacin St (clindamycin Phosphate) Review and Dalacin St (clindamycin Phosphate) Label ).

6750450-3 | Aspergillosis, Axillary Vein Thrombosis, Blood Sodium Decreased, Chronic Respiratory Failure, Coma, Cytolytic Hepatitis, Disease Progression, Disease Recurrence, Haemoglobin Decreased
Patient was taking Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: aspergillosis, axillary vein thrombosis, blood sodium decreased, chronic respiratory failure, coma, cytolytic hepatitis, disease progression, disease recurrence, haemoglobin decreased on May 21, 2010 from FRANCE Additional patient health information: Female patient , 44 years of age, weighting 99.21 lb, was diagnosed with zygomycosis, headache (What is headache?) and. Ambisome dosage: 300, D, Iv Nos, 3 Mg/kg, Uid/qd, Iv Nos, 10 Mg/kg, Uid/qd, Iv Nos. During the same period patient was treated with TRAMADOL HCL (50, D, Oral) (View Tramadol Hcl Review and Tramadol Hcl Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ISOPOTINE (VERAPAMIL HYDROCHLORIDE) (View Isopotine (verapamil Hydrochloride) Review and Isopotine (verapamil Hydrochloride) Label ), HYPERIUM (RILMENIDINE PHOSPHATE) (View Hyperium (rilmenidine Phosphate) Review and Hyperium (rilmenidine Phosphate) Label ).

6746857-0 | Bronchopulmonary Aspergillosis, Diarrhoea, Fatigue, Nervous System Disorder, No Therapeutic Response, Pancreatitis, Renal Failure, Respiratory Failure, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on May 18, 2010 by a Male patient taking Ambisome (View Usage) (Dosage: 3 Mg/kg, 3xweekly, Iv Nos; 7 Mg/kg, Weekly, Iv Nos) was diagnosed with myelofibrosis, graft versus host disease and. Location: ITALY , 58 years of age, Patient had the following side effects: bronchopulmonary aspergillosis, diarrhoea, fatigue, nervous system disorder, no therapeutic response, pancreatitis, renal failure, respiratory failure, thrombotic thrombocytopenic purpura. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

6743361-0 | Acute Lymphocytic Leukaemia, Blood Potassium Decreased, Bronchopulmonary Aspergillosis, Condition Aggravated, Disseminated Intravascular Coagulation, No Therapeutic Response, Renal Impairment, Respiratory Failure, Torsade De Pointes
on Mar 18, 2009 Male patient from JAPAN , 14 years of age, weighting 167.6 lb, was diagnosed with bronchopulmonary aspergillosis, fungal infection (What is fungal infection?), sepsis (What is sepsis?), white blood cell count decreased and was treated with Ambisome (View Usage). After Ambisome was administered, patient had the following side effects: acute lymphocytic leukaemia, blood potassium decreased, bronchopulmonary aspergillosis, condition aggravated, disseminated intravascular coagulation, no therapeutic response, renal impairment, respiratory failure, torsade de pointes. Ambisome dosage: 350 Mg, Uid/qd, Iv Nos. During the same period patient was treated with FUNGUARD (MICAFUNGIN) INJECTION (150 Mg, Uid/qd, Iv Nos) (View Funguard (micafungin) Injection Review and Funguard (micafungin) Injection Label ), VFEND (400 Mg, Uid/qd, Iv Nos; 200 Mg, Bid, Iv Nos) (View Vfend Review and Vfend Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), AMIKACIN SULFATE (400 Mg, Uid/qd, Iv Nos; 200 Mg, Uid/qd, Iv Nos) (View Amikacin Sulfate Review and Amikacin Sulfate Label ), NEUTROGIN (LENOGRASTIM) (250 Ug, Uid/qd, Iv Nos; 450 Ug, Uid/qd, Iv Nos) (View Neutrogin (lenograstim) Review and Neutrogin (lenograstim) Label ).

6743318-X | Blood Pressure Decreased, Bone Marrow Failure, Cardiac Failure Acute, Histiocytosis Haematophagic, Hypertension, Muscle Mass, Pancreatitis Acute, Polyneuropathy, Renal Failure Acute
on May 17, 2010 Female patient from JAPAN , 16 years of age, weighting 105.8 lb, was diagnosed with candidiasis, sepsis (What is sepsis?) and was treated with Ambisome (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, bone marrow failure, cardiac failure acute, histiocytosis haematophagic, hypertension, muscle mass, pancreatitis acute, polyneuropathy, renal failure acute. Ambisome dosage: 125 Mg, Uid/qd, Iv Nos; 230 Mg, Uid/qd, Iv Nos. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), NOVANTRON (MITOXANTRONE HYDROCHLORIDE) INJECTION (View Novantron (mitoxantrone Hydrochloride) Injection Review and Novantron (mitoxantrone Hydrochloride) Injection Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ).

6738114-3 | Cerebrovascular Accident, Coma, Pyrexia, Transplant Failure
Patient was taking Ambisome (View Usage). Patient had the following side effects: cerebrovascular accident, coma, pyrexia, transplant failure on May 14, 2010 from ITALY Additional patient health information: Male patient , 58 years of age, weighting 156.5 lb, . Ambisome dosage: 3 Mg/kg, 3xweekly, Iv Nos. During the same period patient was treated with CERNEVIT 12 (View Cernevit-12 Review and Cernevit-12 Label ), FOSCAVIR (View Foscavir Review and Foscavir Label ), BICARBONATE (SODIUM BICARBONATE) (View Bicarbonate (sodium Bicarbonate) Review and Bicarbonate (sodium Bicarbonate) Label ), PARACETAMOLO (PARACETAMOL) (View Paracetamolo (paracetamol) Review and Paracetamolo (paracetamol) Label ), PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM (View Piperacillin Sodium And Tazobactam Sodium Review and Piperacillin Sodium And Tazobactam Sodium Label ), ALIZAPRIDE (ALIZAPRIDE) (View Alizapride (alizapride) Review and Alizapride (alizapride) Label ), FARGANESSE (PROMETHAZINE HYDROCHLORIDE) (View Farganesse (promethazine Hydrochloride) Review and Farganesse (promethazine Hydrochloride) Label ).